Lemaitre Vascular (LMAT) Tops Q2 EPS by 4c, Beats on Revenue; Offers FY23 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $84.45 -1.03%
Revenue Growth %: +11.0%
Financial Fact:
Cost of sales: 6.2M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +11.0%
Financial Fact:
Cost of sales: 6.2M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.36, $0.04 better than the analyst estimate of $0.32. Revenue for the quarter came in at $50.1 million versus the consensus estimate of $48.08 million.
GUIDANCE:
Lemaitre Vascular sees FY2023 EPS of $1.25-$1.35, versus the consensus of $1.20. Lemaitre Vascular sees FY2023 revenue of $193-198 million, versus the consensus of $189.9 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Wells Fargo Names Top Pick Ahead of Q3 Earnings
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
